Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction

Biochemistry

Volumn 45, Issue 4, 2006, Pages 1128-1137

  Chen, Min ^a   Aprahamian, Charles J ^a   Celik, Ahmet ^a   Georgeson, Keith E ^a   Garvey, W Timothy ^b   Harmon, Carroll M ^a   Yang, Yingkui ^a  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOCHEMISTRY; BIOLOGICAL ORGANS; CHARACTERIZATION; GENETIC ENGINEERING; MATHEMATICAL MODELS; NITROGEN COMPOUNDS; SIGNAL RECEIVERS;

ENERGY HOMEOSTASIS; LIGAND RECEPTOR INTERACTION; MELANOCORTIN-3 RECEPTOR (MC3R); RECEPTOR ACTIVATION;

PIGMENTS;

ALANINE; ALPHA INTERMEDIN DERIVATIVE; AMINO ACID; ASPARTIC ACID; HISTIDINE; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 3 RECEPTOR BLOCKING AGENT; MELANOCORTIN 3 RECEPTOR STIMULATING AGENT; METHIONINE; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; N ACETYLSERYLTYROSYLSERYLNORLEUCYLGLUTAMYLHISTIDYL DEXTRO PHENYLALANYLARGINYLTRYPTOPHYLGLYCYLLYSYLPROLYLVALINAMIDE; PHENYLALANINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPOTHALAMUS; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

ALPHA-MSH; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO ACIDS, AROMATIC; HUMANS; KINETICS; LIGANDS; MELANOCYTE-STIMULATING HORMONES; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 31544441358     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0521792     Document Type: Article

References (33)

1. Kopelman, P. G. (2000) Obesity as a medical problem, Nature 404, 635-643.
2. Flegal, K. M., Carroll, M. D., Ogden, C. L., and Johnson, C. L. (2002) Prevalence and trends in obesity among U.S. adults, 1999-2000, JAMA 288, 1723-1727.
3. Allison, D. B., Fontaine, K. R., Manson, J. E., Stevens, J., and VanItallie, T. B. (1999) Annual deaths attributable to obesity in the United States, JAMA 282, 1530-1538.
4. Zimmermann-Belsing, T., and Feldt-Rasmussen, U. (2004) Obesity: the new worldwide epidemic threat to general health and our complete lack of effective treatment, Endocrinology 145, 1501-1502.
5. Yang, Y. K., Fong, T. M., Dickinson, C. J., Mao, C., Li, J. Y., Tota, M. R., Mosley, R., Van Der Ploeg, L. H., and Gantz, I. (2000) Molecular determinants of ligand binding to the human melanocortin-4 receptor, Biochemistry 39, 14900-14911.
6. Kowalski, T. J. (2004) The future of genetic research on appetitive behavior, Appetite 42, 11-14.
7. Damcott, C. M., Moffett, S. P., Feingold, E., Barmada, M. M., Marshall, J. A., Hamman, R. F., and Ferrell, R. E. (2004) Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males, Metabolism 53, 303-309.
8. Geller, F., Reichwald, K., Dempfle, A., Illig, T., Vollmert, C., Herpertz, S., Siffert, W., Platzer, M., Hess, C., Gudermann, T., Biebermann, H., Wichmann, H. E., Schafer, H., Hinney, A., and Hebebrand, J. (2004) Melanocortin-4 receptor gene variant I103 is negatively associated with obesity, Am. J. Hum. Genet. 74, 572-581.
9. Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., Smith, F. J., Campfield, L. A., Burn, P., and Lee, F. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice, Cell 88, 131-141.
10. Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., and Cone, R. D. (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome, Nature 385, 165-168.
11. Giraudo, S. Q., Billington, C. J., and Levine, A. S. (1998). Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands, Brain Res. 809, 302-306.
12. Cone, R. D. (1999) The central melanocortin system and energy homeostasis, Trends Endocrinol. Metab. 10, 211-216.
13. Fisher, S. L., Yagaloff, K. A., and Burn, P. (1999) Melanocortin-4 receptor, a novel signalling pathway involved in body weight regulation, Int. J. Obes. Relat. Metab. Disord. 23 Suppl 1, 54-58.
14. Chen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X. M., Yu, H., Rosenblum, C. I., Vongs, A., Feng, Y., Cao, L., Metzger, J. M., Strack, A. M., Camacho, R. E., Mellin, T. N., Nunes, C. N., Min, W., Fisher, J., Gopal-Truter, S., MacIntyre, D. E., Chen, H. Y., and Van der Ploeg, L. H. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass, Nat. Genet. 26, 97-102.
15. Butler, A. A., Kesterson, R. A., Khong, K., Cullen, M. J., Pelleymounter, M. A., Dekoning, J., Baetscher, M., and Cone, R. D. (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse, Endocrinology 141, 3518-3521.
16. Tao, Y. X., and Segaloff, D. L. (2004) Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation, J. Clin. Endocrinol. Metab. 89, 3936-3942.
17. Yang, Y. K., Ollmann, M. M., Wilson, B. D., Dickinson, C., Yamada, T., Barsh, G. S., and Gantz, I. (1997) Effects of recombinant agouti-signaling protein on melanocortin action, Mol. Endocrinol. 11, 274-280.
18. Yang, Y. K., Dickinson, C., Lai, Y. M., Li, J. Y., and Gantz, I. (2001) Functional properties of an agouti signaling protein variant and characteristics of its cognate radioligand, Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1877-1886.
19. Yang, Y. K., Thompson, D. A., Dickinson, C. J., Wilken, J., Barsh, G. S., Kent, S. B., and Gantz, I. (1999) Characterization of Agouti-related protein binding to melanocortin receptors, Mol. Endocrinol. 13, 148-155.
20. Yang, Y., Dickinson, C., Haskell-Luevano, C., and Gantz, I. (1997) Molecular basis for the interaction of [Nle4, D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor, J. Biol. Chem. 272, 23000-23010.
21. Tritos, N. A., and Maratos-Flier, E. (1999) Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone, Neuropeptides 33, 339-349.
22. Guan, X. M., Kobilka, T. S., and Kobilka, B. K. (1992) Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide, J. Biol. Chem. 267, 21995-21998.
23. Haskell-Luevano, C., Sawyer, T. K., Trumpp-Kallmeyer, S., Bikker, J. A., Humblet, C., Gantz, I., and Hruby, V. J. (1996) Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists, Drug Des. Discov. 14, 197-211.
24. Haskell-Luevano, C., Cone, R. D., Monck, E. K., and Wan, Y. P. (2001) Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants, Biochemistry 40, 6164-6179.
25. Yang, Y., Chen, M., Lai, Y., Gantz, I., Georgeson, K. E., and Harmon, C. M. (2002) Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity, J. Biol. Chem. 277, 20328-20335.
26. Holder, J. R., and Haskell-Luevano, C. (2004) Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies, Med. Res. Rev. 24, 325-356.
27. Gether, U. (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors, Endocr. Rev. 21, 90-113.
28. Sawyer, T. K., Sanfilippo, P. J., Hruby, V. J., Engel, M. H., Heward, C. B., Burnett, J. B., and Hadley, M. E. (1980) 4-Norleucine, 7-D-phenylalanine- alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity, Proc. Natl. Acad. Sci. U.S.A. 77, 5754-5758.
29. Dong, M., Liu, G., Pinon, D. I., and Miller, L. J. (2005) Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling, Biochemistry 44, 6693-6700.
30. Macdonald, D., Mierke, D. F., Li, H., Pellegrini, M., Sachais, B., Krause, J. E., Leeman, S. E., and Boyd, N. D. (2001) Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex, Biochemistry 40, 2530-2539.
31. Tan, Y. V., Couvineau, A., Van Rampelbergh, J., and Laburthe, M. (2003) Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor, J. Biol. Chem. 278, 36531-36536.
32. Matsuura, B., Dong, M., Coulie, B., Pinon, D. I., and Miller, L. J. (2005) Demonstration of a specific site of covalent labeling of the human motilin receptor using a biologically active photolabile motilin analogue, J. Pharmacol. Exp. Ther. 313, 1101-1108.
33. Matsuura, B., Dong, M., and Miller, L. J. (2002) Differential determinants for peptide and non-peptidyl ligand binding to the motilin receptor. Critical role of second extracellular loop for peptide binding and action, J. Biol. Chem. 277, 9834-9839.